$USM
UNITED STATES CELLULAR CORP Stock $usm

$usm Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000082113022000025 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$1.010B	$1.023B
YoY Change	-1.27%	6.23%
Cost Of Revenue	$442.0M	$460.0M
YoY Change	-3.91%	15.87%
Gross Profit	$568.0M	$563.0M
YoY Change	0.89%	-0.53%
Gross Profit Margin	56.24%	55.03%
Selling, General & Admin	$325.0M	$305.0M
YoY Change	6.56%	-8.96%
% of Gross Profit	57.22%	54.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$171.0M	$170.0M
YoY Change	0.59%	-3.95%
% of Gross Profit	30.11%	30.2%
Operating Expenses	$939.0M	$939.0M
YoY Change	0.0%	2.85%
Operating Profit	$71.00M	$84.00M
YoY Change	-15.48%	68.0%
Interest Expense	$33.00M	$39.00M
YoY Change	-15.38%	62.5%
% of Operating Profit	46.48%	46.43%
Other Income/Expense, Net	$13.00M	$5.000M
YoY Change	160.0%	-80.77%
Pretax Income	$84.00M	$89.00M
YoY Change	-5.62%	17.11%
Income Tax	$32.00M	$27.00M
% Of Pretax Income	38.1%	30.34%
Net Earnings	$49.00M	$60.00M
YoY Change	-18.33%	-15.49%
Net Earnings / Revenue	4.85%	5.87%
Basic Earnings Per Share	$0.57	$0.70
Diluted Earnings Per Share	$0.57	$0.69
COMMON SHARES
Basic Shares Outstanding	86.00M shares	86.00M shares
Diluted Shares Outstanding	87.00M shares	88.00M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.0M	$482.0M
YoY Change	-37.76%	86.82%
Cash & Equivalents	$300.0M	$479.0M
Short-Term Investments		$3.000M
Other Short-Term Assets	$51.00M	$43.00M
YoY Change	18.6%	95.45%
Inventory	$177.0M	$139.0M
Prepaid Expenses	$63.00M	$63.00M
Receivables	$964.0M	$900.0M
Other Receivables	$50.00M	$209.0M
Total Short-Term Assets	$1.611B	$1.845B
YoY Change	-12.68%	17.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.576B	$2.419B
YoY Change	6.49%	6.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$451.0M	$447.0M
YoY Change	0.89%	-3.04%
Other Assets	$579.0M	$580.0M
YoY Change	-0.17%	8.61%
Total Long-Term Assets	$9.264B	$8.303B
YoY Change	11.57%	24.39%
TOTAL ASSETS
Total Short-Term Assets	$1.611B	$1.845B
Total Long-Term Assets	$9.264B	$8.303B
Total Assets	$10.88B	$10.15B
YoY Change	7.16%	22.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$281.0M	$282.0M
YoY Change	-0.35%	-14.02%
Accrued Expenses	$207.0M	$207.0M
YoY Change	0.0%	13.11%
Deferred Revenue	$200.0M	$158.0M
YoY Change	26.58%	13.67%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$2.000M
YoY Change	200.0%	-66.67%
Total Short-Term Liabilities	$873.0M	$739.0M
YoY Change	18.13%	2.35%
LONG-TERM LIABILITIES
Long-Term Debt	$3.220B	$2.981B
YoY Change	8.02%	98.34%
Other Long-Term Liabilities	$583.0M	$393.0M
YoY Change	48.35%	20.18%
Total Long-Term Liabilities	$583.0M	$393.0M
YoY Change	48.35%	20.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$873.0M	$739.0M
Total Long-Term Liabilities	$583.0M	$393.0M
Total Liabilities	$1.456B	$1.132B
YoY Change	28.62%	7.91%
SHAREHOLDERS EQUITY
Retained Earnings	$2.897B	$2.796B
YoY Change	3.61%	6.72%
Common Stock	$88.00M	$88.00M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$77.00M	$66.00M
YoY Change	16.67%	-28.26%
Treasury Stock Shares
Shareholders Equity	$4.593B	$4.475B
YoY Change
Total Liabilities & Shareholders Equity	$10.88B	$10.15B
YoY Change	7.16%	22.99%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$49.00M	$60.00M
YoY Change	-18.33%	-15.49%
Depreciation, Depletion And Amortization	$171.0M	$170.0M
YoY Change	0.59%	-3.95%
Cash From Operating Activities	$311.0M	$124.0M
YoY Change	150.81%	-63.74%
INVESTING ACTIVITIES
Capital Expenditures	-$711.0M	-$1.389B
YoY Change	-48.81%	307.33%
Acquisitions
YoY Change
Other Investing Activities	$1.000M	$1.000M
YoY Change	0.0%
Cash From Investing Activities	-$710.0M	-$1.388B
YoY Change	-48.85%	305.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$10.00M	$2.000M
YoY Change	400.0%	-90.48%
Debt Paid & Issued, Net	$126.0M	$0.00
YoY Change		-100.0%
Cash From Financing Activities	$544.0M	$485.0M
YoY Change	12.16%	-2120.83%
NET CHANGE
Cash From Operating Activities	$311.0M	$124.0M
Cash From Investing Activities	-$710.0M	-$1.388B
Cash From Financing Activities	$544.0M	$485.0M
Net Change In Cash	$145.0M	-$779.0M
YoY Change	-118.61%	3145.83%
FREE CASH FLOW
Cash From Operating Activities	$311.0M	$124.0M
Capital Expenditures	-$711.0M	-$1.389B
Free Cash Flow	$1.022B	$1.513B
YoY Change	-32.45%	121.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000821130
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-09712
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	UNITED STATES CELLULAR CORPORATION
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1147325
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8410 West Bryn Mawr
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60631
CY2022Q1	dei	City Area Code CityAreaCode	(773)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	399-8900
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Revenues Revenues	1010000000	USD
CY2021Q1	us-gaap	Revenues Revenues	1023000000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	325000000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	305000000	USD
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	171000000	USD
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	170000000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2000000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5000000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1000000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1000000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	939000000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	939000000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	71000000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	84000000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42000000	USD
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1000000	USD
CY2021Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2000000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	33000000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	39000000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13000000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	84000000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	89000000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	52000000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	62000000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	49000000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	60000000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86000000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88000000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2022Q1	us-gaap	Profit Loss ProfitLoss	52000000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	62000000	USD
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	171000000	USD
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	170000000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25000000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7000000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7000000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6000000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22000000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23000000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42000000	USD
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	19000000	USD
CY2021Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	22000000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2000000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-5000000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15000000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1000000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1000000	USD
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1000000	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000000	USD
CY2022Q1	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	0	USD
CY2021Q1	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	18000000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4000000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7000000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-62000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-86000000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	9000000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	7000000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	130000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	3000000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	126000000	USD
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10000000	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	9000000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	53000000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	311000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	124000000	USD
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	150000000	USD
CY2021Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	133000000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	561000000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1256000000	USD
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1000000	USD
CY2021Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1000000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-710000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1388000000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	625000000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	492000000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	60000000	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2022Q1	usm	Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options PaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2021Q1	usm	Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options PaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1000000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10000000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2000000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000000	USD
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1000000	USD
CY2021Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1000000	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3000000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2000000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	544000000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	485000000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	145000000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-779000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	199000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1291000000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344000000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	512000000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156000000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59000000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	57000000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	964000000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	976000000	USD
CY2022Q1	usm	Receivables Net Current Roaming ReceivablesNetCurrentRoaming	5000000	USD
CY2021Q4	usm	Receivables Net Current Roaming ReceivablesNetCurrentRoaming	7000000	USD
CY2022Q1	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	1000000	USD
CY2021Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	0	USD
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	1000000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2000000	USD
CY2022Q1	us-gaap	Other Receivables OtherReceivables	50000000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	63000000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	177000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	173000000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	63000000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58000000	USD
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	123000000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	51000000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	49000000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1611000000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1605000000	USD
CY2022Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	15000000	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	18000000	USD
CY2022Q1	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	4677000000	USD
CY2021Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	4088000000	USD
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	465000000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	439000000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9136000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9056000000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6560000000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6450000000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2576000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2606000000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	952000000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	959000000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	579000000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	626000000	USD
CY2022Q1	us-gaap	Assets Assets	10875000000	USD
CY2021Q4	us-gaap	Assets Assets	10341000000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	6000000	USD
CY2022Q1	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	9000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	3000000	USD
CY2021Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	14000000	USD
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	272000000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	346000000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	191000000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	34000000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	33000000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	42000000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	83000000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	131000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	129000000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	179000000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	104000000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	873000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	903000000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	696000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	674000000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	882000000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	889000000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	583000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	573000000	USD
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3220000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2728000000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Other Carrying Amount RedeemableNoncontrollingInterestEquityOtherCarryingAmount	12000000	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Other Carrying Amount RedeemableNoncontrollingInterestEquityOtherCarryingAmount	11000000	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86000000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	88000000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	88000000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1685000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1678000000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	77000000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	68000000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2897000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2849000000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4593000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4547000000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	16000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	16000000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4609000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4563000000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10875000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10341000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4563000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	49000000	USD
CY2022Q1	usm	Minority Interest In Net Income Loss Equity Minority Interests MinorityInterestInNetIncomeLossEquityMinorityInterests	1000000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	10000000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7000000	USD
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1000000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4609000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4426000000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	60000000	USD
CY2021Q1	usm	Minority Interest In Net Income Loss Equity Minority Interests MinorityInterestInNetIncomeLossEquityMinorityInterests	1000000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2000000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6000000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1000000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4490000000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156000000	USD
CY2022Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	44000000	USD
CY2021Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	43000000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	199000000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	988000000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1003000000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	22000000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	20000000	USD
CY2022Q1	us-gaap	Revenues Revenues	1010000000	USD
CY2021Q1	us-gaap	Revenues Revenues	1023000000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	6000000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	7000000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	257000000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	243000000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	109000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	216000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	131000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	92000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	439000000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	122000000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	126000000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	25000000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	25000000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1069000000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1085000000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	73000000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	72000000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	996000000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1013000000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	996000000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1013000000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1069000000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1085000000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	16000000	USD
CY2022Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	229000000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	627000000	USD
CY2022Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	197000000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1069000000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	49000000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	60000000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86000000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87000000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88000000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	4088000000	USD
CY2022Q1	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	586000000	USD
CY2022Q1	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	1000000	USD
CY2022Q1	usm	Indefinite Lived Intangible Assets Acquired In Exchange IndefiniteLivedIntangibleAssetsAcquiredInExchange	1000000	USD
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1000000	USD
CY2022Q1	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	4677000000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	451000000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	431000000	USD
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4000000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8000000	USD
CY2022Q1	usm	Investments Recorded Using The Net Asset Value Practical Expedient InvestmentsRecordedUsingTheNetAssetValuePracticalExpedient	10000000	USD
CY2021Q4	usm	Investments Recorded Using The Net Asset Value Practical Expedient InvestmentsRecordedUsingTheNetAssetValuePracticalExpedient	0	USD
CY2022Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	465000000	USD
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	439000000	USD
CY2022Q1	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	5000000	USD
CY2021Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	4000000	USD
CY2022Q1	us-gaap	Variable Interest Entity Financial Or Other Support Amount VariableInterestEntityFinancialOrOtherSupportAmount	21000000	USD
CY2021Q1	us-gaap	Variable Interest Entity Financial Or Other Support Amount VariableInterestEntityFinancialOrOtherSupportAmount	30000000	USD

Files In Submission

Name	View Source	Status
0000821130-22-000025-index-headers.html	Edgar Link	pending
0000821130-22-000025-index.html	Edgar Link	pending
0000821130-22-000025.txt	Edgar Link	pending
0000821130-22-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usm-20220331.htm	Edgar Link	pending
usm-20220331.xsd	Edgar Link	pending
usm-20220331_cal.xml	Edgar Link	unprocessable
usm-20220331_def.xml	Edgar Link	unprocessable
usm-20220331_g1.jpg	Edgar Link	pending
usm-20220331_g2.jpg	Edgar Link	pending
usm-20220331_g3.jpg	Edgar Link	pending
usm-20220331_g4.jpg	Edgar Link	pending
usm-20220331_g5.jpg	Edgar Link	pending
usm-20220331_g6.jpg	Edgar Link	pending
usm-20220331_g7.jpg	Edgar Link	pending
usm-20220331_htm.xml	Edgar Link	completed
usm-20220331_lab.xml	Edgar Link	unprocessable
usm-20220331_pre.xml	Edgar Link	unprocessable
usm331202210qex101.htm	Edgar Link	pending
usm331202210qex103.htm	Edgar Link	pending
usm331202210qex104.htm	Edgar Link	pending
usm331202210qex105.htm	Edgar Link	pending
usm331202210qex106.htm	Edgar Link	pending
usm331202210qex107.htm	Edgar Link	pending
usm331202210qex108.htm	Edgar Link	pending
usm331202210qex109.htm	Edgar Link	pending
usm3312022ex311.htm	Edgar Link	pending
usm3312022ex312.htm	Edgar Link	pending
usm3312022ex321.htm	Edgar Link	pending
usm3312022ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USM
UNITED STATES CELLULAR CORP Stock $usm

2022 Q1 Form 10-Q Financial Statement

#000082113022000025 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USM UNITED STATES CELLULAR CORP Stock $usm

2022 Q1 Form 10-Q Financial Statement

#000082113022000025 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USM
UNITED STATES CELLULAR CORP Stock $usm